Searched for
BUDGET PHARMA INDUSTRY
L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- JP Morgan warns of FY27 earnings risk, says Nifty can fall to 20,500 in bear caseJP Morgan has cautioned that India’s FY27 earnings face significant risks from an extended energy and logistics shock linked to the Middle ...
- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- ‘No coders or managers’: 1 lakh tech jobs gone, but one type of engineer is becoming untouchable, and the ₹60.5 lakh crore reason whyTech giants are shedding over 1 lakh jobs in 2026, including significant cuts at LinkedIn, Cisco, and PayPal, despite record AI investments...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Drug regulator transfers 95 officials in mass reshuffleThe Central Drugs Standard Control Organisation has moved about 95 officials across India. This reshuffle aims to improve compliance and le...
- Pharma exports fall to five-year low in March amid West Asia crisisIndia's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...
- Budget 2026: Sitharaman launches 'Biopharma Shakti' with a Rs 10,000-crore bet to heal India, power manufacturingUnion Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...
- Eco Survey administers a big dose of reality to Indian pharmaThe Economic Survey 2024-25 emphasises the need for increased innovation, new drug development, and biopharmaceutical advancements in India...
- Pharma industry wants Budget to announce incentives for conducting R&D"An increase in the budgetary allocation from the current 1.8 per cent of the GDP to 2.5-3 per cent, as envisaged in the National Health Po...
- Pharma industry seeks enhanced funds for healthcare sector, ease of doing biz in BudgetThe industry is also seeking simplification of various processes in order to enhance ease of doing business for the private sector companie...
- Budget 2021: BSE Healthcare Index closes flatThe words ‘pharma’, 'drug' or 'medicine' does not have any mention in the Budget speech. Little wonder then that the BSE Healthcare Index c...
- COVID-19 pandemic underlines need for higher budget allocation for healthcare sectorThe pharma sector which has played a leading role as the 'pharmacy of the world' said it expects support and incentives especially for rese...
- Budget 2018 expectation: Govt's facilitation a vital cog in pharma industry growthTechnological competitiveness is vital for the boom in the healthcare and pharmaceutical space.
- Pharma industry wants budget to offer tax clarityThe industry players also want the government to provide a road map towards bringing down corporate income tax down to 25 per cent.
- Budget 2014: Pharma industry's expectationsA holistic approach is needed to expand healthcare in India and OPPI believes that there is a need to balance innovation with access and af...
- Budget 2013: Impact on pharma industryThe sharp increase in the rate of surcharge from 5% to 10% would have a negative impact on companies in the pharma sector.
- Budget 2012: Increase expenditure on R&D to help pharma industryGovernment should also think about enabling pharma companies to take their new inventions to the global markets.
- Union Budget 2011: Increased excise duty, MAT on SEZs to hurt pharma industry'There is as expected nothing for the pharma industry, expect an increase in excise duty from 4 per cent to 5 per cent.'
Load More
